Companies / Santa Cruz Biotechnology / CD133 Lentiviral Activation Particles (m)
Santa Cruz Biotechnology

CD133 Lentiviral Activation Particles (m) | Santa Cruz Biotechnology

Lentiviral Activation Particles encode a synergistic activation mediator (SAM) transcription activation system designed to specifically and efficiently upregulate gene expression via lentiviral transduction of cells

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.